Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trialsKlaus Mross
Journal of Angiogenesis Research|June 24, 2010
Clinical trials with anti-angiogenic agents in hematological malignanciesMichael Medinger, Klaus Mross
European Journal of Cancer (Oxford, England : 1990)|November 19, 2005
Peripheral neuropathy: a persisting challenge in paclitaxel-based regimesStephan Mielke, Alex Sparreboom, Klaus Mross
Anticancer Research|December 13, 2005
Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimenStephan Mielke, Alex Sparreboom, Dirk Behringer, et al.
Onkologie|September 12, 2009
Phase II STUdy with 3rd- or 4th-line bendamustine (flat dose) therapy in patients with metastatic breast cancerSimone Steinbild, Annette Frost, Brigitte Häring, et al.
Onkologie|July 29, 2006
Treatment of anthracycline extravasation with dexrazoxane -- clinical experienceAnnette Frost, Daniela Gmehling, Marc Azemar, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 24, 2012
Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarkerFriederike Kanefendt, Andreas Lindauer, Klaus Mross, et al.
Onkologie|October 10, 2006
PAC fixed dose: pharmacokinetics of a 1-hour paclitaxel infusion and comparison to BSA-normalized drug dosingKlaus Mross, Norbert Holländer, Annette Frost, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2010
First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumoursClemens Unger, Wolfgang Berdel, Axel-R Hanauske, et al.
Pageof 4